MAP1LC3B and cancer: Similarly, Fdb treatment with a suboptimal dose can reduce drug toxicity in both normal and cancer cells, but the cells showed a difference in their ability to induce the mediators of cell survival, such as Beclin-1 (anti-apoptosis), found downstream of mTOR and LC3B.